期刊文献+

血浆sRAGE水平与慢性阻塞性肺疾病关系的Meta分析 被引量:2

Meta analysis on relationship between plasma sRAGE level and COPD
下载PDF
导出
摘要 目的综合评价血浆可溶性糖基化终产物受体(sRAGE)水平与慢性阻塞性肺疾病的关系。方法通过计算机联网检索中国生物医学文献数据库、中国学术期刊全文数据库、Medline、Pubmed等数据库,收集2014年4月以前国内外公开发表的有关血浆sRAGE水平与慢性阻塞性肺疾病关系的研究文献。按照纳入与排除标准,选择6篇文献进行Meta分析。结果经Meta分析一致性检验,各研究结果间存在异质性,采用随机效应模型,其合并标准化均数差(SMD)值可信区间(CI)为-1.15,95%CI-1.62^-0.68。结论血浆sRAGE水平降低提示增加COPD发生的风险。 Objective To evaluate the relationship between plasma sRAGE level and COPD. Methods These papers about the relationship between plasma sRAGE level and COPD published before April 2014 were collected from CMB,CNKI,Medline,Pubmed and so on. According to inclusion and exclusion criteria,a total of 6 related papers were suitable for meta-analysis. Results Meta-analysis showed these papers were inhomogeneous. Therefore a random effect model was used. Standard mean was different and 95% CI were- 1. 17(- 2. 05^- 0. 29). Conclusions The decrease of plasma sRAGE level increases the risk of COPD.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2015年第17期4914-4915,共2页 Chinese Journal of Gerontology
基金 国家自然科学基金项目(71273077)
  • 相关文献

参考文献14

  • 1Piera Boschetto,Ilaria Campo,Mariarita Stendardo,Enrico Casimirri,Carmine Tinelli,Marina Gorrini,Claudio Ceconi,Alessandro Fucili,Alfredo Potena,Alberto Papi,Licia Ballerin,Leonardo Fabbri,Maurizio Luisetti.Plasma s RAGE and N ‐(carboxymethyl) lysine in patients with CHF and/or COPD[J]. Eur J Clin Invest . 2013 (6)
  • 2Poornima Gopal,Erica P. A. Rutten,Mieke A. Dentener,Emiel F. M. Wouters,Niki L. Reynaert.Decreased plasma sRAGE levels in COPD: influence of oxygen therapy[J]. European Journal of Clinical Investigation . 2012 (8)
  • 3Alison Goldin,Joshua A. Beckman,Ann Marie Schmidt,Mark A. Creager.Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury[J]. Circulation . 2006 (6)
  • 4Nina Demling,Carsten Ehrhardt,Michael Kasper,Michael Laue,Lilla Knels,Ernst Peter Rieber.Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells[J]. Cell and Tissue Research . 2006 (3)
  • 5N Yamakawa,T Uchida,MA Matthay,K Makita.Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. American journal of physiology. Lung cellular and molecular physiology . 2011
  • 6Uchida Tokujiro,Shirasawa Madoka,Ware Lorraine B,Kojima Katsuo,Hata Yutaka,Makita Koshi,Mednick Gabe,Matthay Zachary A,Matthay Michael A.Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. American Journal of Respiratory and Critical Care Medicine . 2006
  • 7Heffner John E,Mularski Richard A,Calverley Peter M A.COPD performance measures: missing opportunities for improving care. Chest . 2010
  • 8D. J. Smith,S. T. Yerkovich,M. A. Towers.Reduced soluble receptor for advanced glycation end-products in COPD. European Respiratory Journal . 2011
  • 9Miniati Massimo,Monti Simonetta,Basta Giuseppina,Cocci Franca,Fornai Edo,Bottai Matteo.Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respiratory Research . 2011
  • 10Cockayne Debra A,Cheng Donavan T,Waschki Benjamin,Sridhar Sriram,Ravindran Palanikumar,Hilton Holly,Kourteva Galina,Bitter Hans,Pillai Sreekumar G,Visvanathan Sudha,Müller Kai-Christian,Holz Olaf,Magnussen Helgo,Watz Henrik,Fine Jay S.Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity. PloS one . 2012

共引文献6

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部